Hypertension Diagnostics (Hypertension Diagnostics) EBITDA Margin % : 0.00% (As of Sep. 2019)

View and export this data going back to 1998. Start your Free Trial

What is Hypertension Diagnostics EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Hypertension Diagnostics's EBITDA for the three months ended in Sep. 2019 was $0.00 Mil. Hypertension Diagnostics's Revenue for the three months ended in Sep. 2019 was $0.00 Mil. Therefore, Hypertension Diagnostics's EBITDA margin for the quarter that ended in Sep. 2019 was 0.00%.

Hypertension Diagnostics EBITDA Margin % Historical Data

The historical data trend for Hypertension Diagnostics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypertension Diagnostics EBITDA Margin % Chart

Hypertension Diagnostics Annual Data

Trend

Jun06

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Dec16

Dec17

Dec18

EBITDA Margin %

Get a 7-Day Free Trial

-38.70

-12.11

-4.87

1.90

Hypertension Diagnostics Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19
EBITDA Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Hypertension Diagnostics's EBITDA Margin %

For the Shell Companies subindustry, Hypertension Diagnostics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypertension Diagnostics's EBITDA Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Hypertension Diagnostics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Hypertension Diagnostics's EBITDA Margin % falls into.

Hypertension Diagnostics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Hypertension Diagnostics's EBITDA Margin % for the fiscal year that ended in Dec. 2018 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2018 )	/	Revenue (A: Dec. 2018 )
	=	0.072	/	3.792
	=	1.90 %

Hypertension Diagnostics's EBITDA Margin % for the quarter that ended in Sep. 2019 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2019 )	/	Revenue (Q: Sep. 2019 )
	=	0	/	0
	=	%

Hypertension Diagnostics (OTCPK:HDII) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Hypertension Diagnostics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Hypertension Diagnostics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.